Virbac SA (VIRP)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA and an Investment Account

Sell

€340.00

Buy

€341.00

arrow-down€-7.50 (-2.16%)

Prices updated at 15 Jun 2026, 16:35 CEST

Prices minimum 15 mins delay

Prices in EUR

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, and it also has its presence in Europe, North America, Far East Asia, India, Africa & Middle East (IMEA), Pacifi ...

FTSE EuroFirst 300

0.18%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

Sector

Healthcare

Industry

Drug Manufacturers - General

Chairman

Mr. Pierre Madelpuech

CEO

-

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

50

Head office

13e rue

Carros

France

06511

+33 492087100

finances@virbac.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Philippe G.H. Capron Director	-
Mr. Olivier Charmeil Independent Director	-
Mr. Cyrille Yann Nicolas Petit Independent Director	-
Ms. Marie-Helene Dick-Madelpuech Chairwoman of the Board	-
Ms. Solene Madelpuech Director	-
Mr. Pierre Madelpuech Vice Chairman of the Board	-
Mr. Luc Thielland Director	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
T. Rowe Price	172,041
T. Rowe Price Associates, Inc.	138,763
T. Rowe Price International Small-Cap Eq	138,224
T. Rowe Price International Discovery Fd	138,224
Amundi Asset Management	118,891

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.